Skip to main content

Biocryst Pharmaceuticals Inc 10-Q for FY2025 Q3

Biocryst Pharmaceuticals Inc (BCRX)

10-Q 2025-11-04 For: 2025-09-30
View Original
Added on April 04, 2026

About this 10-Q

Biocryst Pharmaceuticals Inc filed this 10-Q on November 4, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$159.4M
up 36.1% from $117.09M a year earlier
Net income
$12.9M
compared with a net loss of $14.03M a year earlier
Diluted EPS
$0.06
compared with -$0.07 a year earlier